BOSTON (MarketWatch) -- Shares of HeartWare International HTWR -15.28% plunged almost 20% to $68.39 in early action Monday. Late Friday, HeartWare released mixed study results for its HeartWare Ventricular Assist System heart pump in the treatment of patients with end-stage heart failure. HeartWare's negative news boosted shares of rival Thoratec Corp. THOR +14.84% , which markets a similar heart-pump called HeartMate II. Shares of Thoratec rallied 14% in early trading.
http://www.marketwatch.com/story/heartware-thoratec-move-on-heart-pump-study-2011-04-18?link=MW_home_latest_news
If only ventracor was still around... I cant believe how much management stuffed VCR up IMO
- Forums
- ASX - By Stock
- HIN
- heartware plummets
heartware plummets
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HIN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online